Kainopharm Limited - pharma in Ernakulam, Kerala, India. FY 2026 financials and compliance.
CIN U33100KL2020PLC063719 Incorporated 19 August 2020 ROC Ernakulam HQ Ernakulam, Kerala, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹2.66 Cr
▲ 16.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.93 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Kainopharm Limited

Data last updated: 27 February 2026

Kainopharm Limited is a public limited company based in Ernakulam, Kerala, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 August 2020, the company has been in operation for over 6 years.

Registered with ROC Ernakulam under CIN U33100KL2020PLC063719.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.93 Cr. It is led by directors including Attupuram Sreekumar and Mohanakurup Anjiliparambil Narayanapillai.

Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: #229/A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a growth of 16% compared to the previous year.

Company Details of Kainopharm Limited
CIN U33100KL2020PLC063719
Registration Number 063719
Incorporation Date 19 August 2020
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    #229/A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308
  • Industry
    Pharma, Drug Formulation & Development
Company report
Kainopharm Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Kainopharm Limited report

Financials, compliance, directors, charges, ownership and filings for Kainopharm Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Kainopharm Limited

Kainopharm Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Kainopharm Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Kainopharm Limited

Kainopharm Limited is currently managed by 14 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Attupuram Sreekumar Director 24 Aug 2020 5 Years 11 Months Current
Mohanakurup Anjiliparambil Narayanapillai Director 19 Aug 2020 6 Years 0 Months Current
Valiyakath Anwar Director 15 Nov 2020 5 Years 9 Months Current
Ravi Sankunny Menon Director 19 Aug 2020 6 Years 0 Months Current
Telny Thomas Chungath Director 24 Aug 2020 5 Years 11 Months Current
Anitha Director 15 Nov 2020 5 Years 9 Months Current
Showing 6 of 14 current directors. View all directors

Financials of Kainopharm Limited FY 2025 filings available

Kainopharm Limited reported revenue of ₹2.66 Cr (up 16.00% YoY) for FY 2025.

Revenue · FY 2025
₹2.66 Cr ▲ 16.00%
Premium access

Ten-year financial statements for Kainopharm Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Kainopharm Limited

Premium access

Shareholding and ownership data for Kainopharm Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Kainopharm Limited

Kainopharm Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Kainopharm Limited

Kainopharm Limited has a workforce of 0 employees as of Mar 31, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Kainopharm Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Kainopharm Limited

Premium access

GST registrations and filing compliance for Kainopharm Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Kainopharm Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Kainopharm Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kainopharm Limited

Premium access

MSME payment history for Kainopharm Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kainopharm Limited

Premium access

Corporate group structure for Kainopharm Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kainopharm Limited

Premium access

MCA filings and documents for Kainopharm Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Kainopharm Limited

Activity
27 Sep 2025
Kainopharm Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Kainopharm Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Directors
15 Nov 2020
Valiyakath Anwar was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 9 months.
Directors
15 Nov 2020
Anitha was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 9 months.
Directors
15 Nov 2020
Kuzhalmannam Lakshminarayanan Sreeram was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 9 months.
Directors
15 Nov 2020
Suresh Krishna Warrier was appointed as a Director on 15 Nov 2020 & has been associated with this company since 5 years 9 months.

Frequently Asked Questions about Kainopharm Limited

Kainopharm Limited is an active public limited company in the pharma sector based in Ernakulam, Kerala, India. It was incorporated on 19 August 2020 (6+ years old) and is registered under CIN U33100KL2020PLC063719.

Kainopharm Limited reported revenue of ₹2.66 Cr for FY 2025 (up 16.00% YoY).

The current directors of Kainopharm Limited are:

The primary industry of Kainopharm Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Kainopharm Limited can be reached at the registered office: #229A – Ccpsr Campus Varikoli P.O Puthencruz, Ernakulam, Kerala, India – 682308.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹3.93 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available